Literature DB >> 9642152

Alternative splicing of the mRNA coding for the human endothelial angiotensin-converting enzyme: a new mechanism for solubilization.

K Sugimura1, X L Tian, S Hoffmann, D Ganten, M Bader.   

Abstract

Angiotensin converting enzyme (ACE) is a zinc metalloprotease anchored in the plasma membrane with a carboxy-terminal hydrophobic domain. In addition, the existence of a soluble form of ACE lacking the transmembrane domain has been reported. We show evidence for the existence of an mRNA specific for this isoform produced by alternative splicing. In human umbilical vein endothelial cells, two ACE mRNAs of different length (4.3 and 3.5 kb) were detected by Northern blot. Ribonuclease protection assays and the sequence of a PCR-amplified cDNA fragment show that the shortened ACE mRNA lacks the exons coding for the transmembrane domain of the protein. As this mRNA could be the source of soluble ACE, plasma ACE activity may be regulated on the level of mRNA processing. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9642152     DOI: 10.1006/bbrc.1998.8813

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Localization of a small genomic region associated with elevated ACE.

Authors:  X Zhu; C A McKenzie; T Forrester; D A Nickerson; U Broeckel; H Schunkert; A Doering; H J Jacob; R S Cooper; M J Rieder
Journal:  Am J Hum Genet       Date:  2000-09-19       Impact factor: 11.025

2.  Cloning and expression of the rat nephrin homolog.

Authors:  H Ahola; S X Wang; P Luimula; M L Solin; L B Holzman; H Holthöfer
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

3.  Association of urinary N-domain Angiotensin I-converting enzyme with plasma inflammatory markers and endothelial function.

Authors:  Fernanda B Fernandes; Frida L Plavnik; Andressa Ms Teixeira; Dejaldo Mj Christofalo; Sergio A Ajzen; Elisa Ms Higa; Fernanda A Ronchi; Ricardo Cc Sesso; Dulce E Casarini
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

4.  Angiotensin-converting enzyme gene polymorphism predicts the time-course of blood pressure response to angiotensin converting enzyme inhibition in the AASK trial.

Authors:  Vibha Bhatnagar; Daniel T O'Connor; Nicholas J Schork; Rany M Salem; Caroline M Nievergelt; Brinda K Rana; Douglas W Smith; George L Bakris; John P Middleton; Keith C Norris; Jackson T Wright; Deanna Cheek; Leena Hiremath; Gabriel Contreras; Lawrence J Appel; Michael S Lipkowitz
Journal:  J Hypertens       Date:  2007-10       Impact factor: 4.844

5.  N-domain isoform of Angiotensin I converting enzyme as a marker of hypertension: populational study.

Authors:  Leila C V Maluf-Meiken; Fernanda B Fernandes; Danielle S Aragão; Fernanda A Ronchi; Maria C C Andrade; Maria C Franco; Andreia C S Febba; Frida L Plavnik; José E Krieger; Jose G Mill; Ricardo C C Sesso; Dulce E Casarini
Journal:  Int J Hypertens       Date:  2012-05-15       Impact factor: 2.420

6.  Association of B2 receptor polymorphisms and ACE activity with ACE inhibitor-induced angioedema in black and mixed-race South Africans.

Authors:  Retsilisitsoe R Moholisa; Brian R Rayner; E Patricia Owen; Sylva L U Schwager; Joalice S Stark; Motassim Badri; Clint L Cupido; Edward D Sturrock
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-04-11       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.